SKI Market

Indian Indices

Sensex

81,537.70 -769.67
( -0.94%)

Global Indices

Nasdaq

49,128.98 -276.04
(-0.56%)

Dow Jones

6,938.97 4.62
(0.07%)

Hang Seng

52,980.85 -866.02
(-1.61%)

Nikkei 225

10,159.04 15.60
(0.15%)

Forex

USD-INR

91.58 0.09
(0.10%)

EUR-INR

107.27 0.14
(0.13%)

GBP-INR

123.20 0.33
(0.27%)

JPY-INR

0.58 0.00
(-0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Glenmark Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532296

INE935A01035

848.3143291

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLENMARK

37.8

55614.72

EPS(TTM)

Face Value()

Div & Yield %

52.14

0.13

Back

max financial services ltd

Board of Balkrishna Industries recommends Second Interim Dividend

Oct 31,2025

Balkrishna Industries announced that the Board of Directors of the Company at its meeting held on 31 October 2025, has recommended a Second Interim Dividend of Rs.4 per share (i.e.200%), subject to the approval of the shareholders.

81,537.70 -769.67 ( -0.94%)

49,128.98 -276.04 (-0.56%)

6,938.97 4.62 (0.07%)

52,980.85 -866.02 (-1.61%)

10,159.04 15.60 (0.15%)

91.58 0.09 (0.10%)

107.27 0.14 (0.13%)

123.20 0.33 (0.27%)

0.58 0.00 (-0.17%)